We are pleased to announce that Alifax S.r.l. has just obtained the MDSAP certificate by TUV SUD America Inc, that qualifies our Quality Management System compliant with the IVD-related regulations of the 5 countries adhering to the Medical Device Single Audit Program (MDSAP): Australia TGA Brazil ANVISA Health Canada USA FDA Japan MHLW/PMDA
HB&L approbation began at the Lapino Clinical Hospital “Mother and Child” On September 25th, HB&L approbation began at the Lapino Clinical Hospital “Mother and Child”. https://mamadeti.ru/clinics/moscow/clinical-hospital-lapino/
The first HB&L delivery to Kazakhstan at the Medical Center of the NAO ZKGMU In August 2020, the first HB&L delivery to Kazakhstan at the Medical Center of the NAO ZKGMU named after Marat Ospanova, Aktobe, took place. https://zkgmu.kz/ru/ HB&L has been registered in the Republic of Kazakhstan since August 2019.
HB&L approbation at the Scientific Medical Center of Oncology HB7L approbation at the Scientific Medical Center of Oncology named after Blokhin https://www.ronc.ru/ Among the protocols used: • rapid screening of patients using a parallel study for residual antimicrobial activity to determine the effectiveness of the prescribed therapy, including in patients with nephrostomy; • rapid…
Alifax team interview at AACC 2019 Alifax team interview by Select Science at AACC 2019, about the new disruptive solution for the microorganism identification in only 1 minute: I-dOne interview
